Powered by

HistoSonics, Non-Invasive Robotics Pioneer, Closes $54 Million Series C Financing

Apr 08, 2019 - PR Newswire

PR Newswire

 HistoSonics, developer of a non-invasive robotics platform and novel beam therapy, announced today that it has closed a $54 million Series C financing.  The round was led by Varian Medical Systems, Inc., the global leader in radiation therapy and oncology solutions, and included healthcare investors Johnson & Johnson Innovation - JJDC, Inc. (JJDC), Lumira Ventures, Venture Investors, the State of Wisconsin Investment Board, as well as participation from existing investors....